Pilot Study Regarding Framing of Risks in Direct-to-Consumer Prescription Drug TV Ads

Data To Support Social and Behavioral Research as Used by the Food and Drug Administration

⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0847 can be found here:

Documents and Forms

Document Name Document Type
Main Study Questionnaire.docx Other-Survey
0847 approval memo for framing risks in DTC Prescription drug TV Ads 2018.doc OMB approval memo IC Document

Information Collection (IC) Details

IC Title:	Pilot Study Regarding Framing of Risks in Direct-to-Consumer Prescription Drug TV Ads	Agency IC Tracking Number:	CDER

IC Status: New

Obligation to Respond: Voluntary

CFR Citation:

Information Collection Instruments:

Document Type	Form No.	Form Name	Instrument File	URL	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Other-Survey			Main Study Questionnaire.docx		Yes	Yes	Fillable Fileable

Line of Business: Health

Subfunction: Consumer Health and Safety

Privacy Act System of Records
Title:	FR Citation:

Number of Respondents: 1,953	Number of Respondents for Small Entity: 0

Affected Public: Individuals or Households

Percentage of Respondents Reporting Electronically: 0 %

	Approved	Program Change Due to Agency Discretion
Annual Number of Responses for this IC	1,953	1,953
Annual IC Time Burden (Hours)	785	785
Annual IC Cost Burden (Dollars)	0	0

Documents for IC

Title	Document	Date Uploaded
OMB approval memo	0847 approval memo for framing risks in DTC Prescription drug TV Ads 2018.doc	06/04/2018

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.